ClinicalTrials.Veeva

Menu

Evaluation of Desensitization Protocols in Reduction of Dentin Hypersensitivity

F

Federal University of Uberlandia

Status

Unknown

Conditions

Dentine Hypersensitivity
Dentin Sensitivity
Hypersensitivity Dentin
Dentin Hypersensitivity

Treatments

Drug: UltraEZ
Drug: Enamelast

Study type

Interventional

Funder types

Other

Identifiers

NCT03076944
CAAE:60751416.1.0000.5152

Details and patient eligibility

About

The aim of this study is through a double blind randomized clinical trial, evaluate the effectiveness of different clinical protocols in the reduction of dentin hypersensitivity. The desensitization approach (single agent or associated agents) and the long-term effectiveness (baseline, 1 week, 2 weeks, 4 weeks, 12 weeks and 24 weeks) will be evaluated. Data will be collected, tabulated and submitted to statistical analysis.

Full description

Dentin hypersensitivity is characterized as an acute and short-term pain with multifactorial etiology. This condition is a clinical challenge due to the different treatment protocols available. Therefore, the aim of this study is through a double blind randomized clinical trial, evaluate the effectiveness of different clinical protocols in the reduction of dentin hypersensitivity. Thirty-two patients with dentin hypersensitivity in at least three teeth will be selected.The teeth will be randomly divided into two different groups according to the desensitization approach (single agent with neural action; single agent with obliterating action; associated technique (neural and obliterator agents). The dentin hypersensitivity level will be evaluated immediately after desensitization and after 1, 2, 4,12 and 24 weeks. Data will be collected, tabulated and submitted to statistical analysis.

Enrollment

32 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy individuals
  • Both genres, interested in the treatment of Dentin Hypersensitivity
  • Patients with all teeth in their mouth
  • Patients who have at least three teeth with Dentin hypersensitivity in different quadrants
  • Good oral hygiene

Exclusion criteria

  • Caries or unsatisfactory restorations
  • Presence of periodontal disease and or parafunctional habits
  • Cracks or enamel fractures
  • Extensive or unsatisfactory restorations
  • Recent restorations involving the labial surface
  • Pulpitis
  • Dentures
  • Orthodontics
  • Smokers
  • Pregnant women
  • Gastroesophageal disease presence
  • Uncontrolled systemic disease
  • Severe bruxism
  • Constant use of analgesic
  • Allergic response to dental products

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

32 participants in 3 patient groups

Neural agent
Active Comparator group
Description:
UltraEZ. Prophylaxis of the teeth; an application every 48 hours; 4 sessions
Treatment:
Drug: UltraEZ
Obliterator agent
Active Comparator group
Description:
Enamelast. Prophylaxis of the teeth; an application every 48 hours; 4 sessions
Treatment:
Drug: Enamelast
Associative approach
Active Comparator group
Description:
UltraEZ and Enamelast. Prophylaxis of the teeth; an application every 48 hours; 4 sessions. In each session, fistly the UltraEZ (neural agent) will be applied and after the Enamelast (obliterator agent.)
Treatment:
Drug: Enamelast
Drug: UltraEZ

Trial contacts and locations

1

Loading...

Central trial contact

Paulo V Soares, DDS,MS,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems